Molecular markers and targeted therapies for adrenocortical carcinoma.

Abstract excerpt

Adrenocortical carcinoma (ACC) is a lethal disease with poor prognosis and lack of effective therapeutic options. Systemic treatment is often employed to treat patients with advanced ACC, but outcomes are disappointing. During the last decade, some of the causative genetic mutations in sporadic ACCs have been identified. Molecular analysis has had a significant impact on the understanding of the pathogenetic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adrenal Cortex Neoplasms
• Share to Adrenocortical Carcinoma
• Share to Antineoplastic Agents